Myriad Genetics to stop developing Alzheimer's drug (Reuters)Reuters - Myriad Genetics Inc said it will stop
developing its drug for Alzheimer's disease after a late-stage
trial of the drug, Flurizan, failed to meet primary goals.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/myriad_flurizan_dc.html